Search Results

Displaying Results 1-2 of 2 "'PROK'"
Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.
Chronic Kidney Disease Market Poised to Expand Significantly During Forecast Period (2025-2034) as Demand for Early Diagnosis and Novel Therapies Increases | DelveInsight

Mar 03, 2026, 17:31 ET Chronic Kidney Disease Market Poised to Expand Significantly During Forecast Period (2025-2034) as Demand for Early Diagnosis and Novel Therapies Increases | DelveInsight

AstraZeneca (LON: AZN), Boehringer Ingelheim, Mineralys Therapeutics (NASDAQ: MLYS), ProKidney (NASDAQ: PROK), Disc Medicine (NASDAQ: IRON), Regeneron Pharmaceuticals (NASDAQ: REGN), AION Healthspan, Amgen (NASDAQ: AMGN), Maze Therapeutics (NASDAQ: MAZE), Eli

More news about: DelveInsight Business Research, LLP

Beyond Insulin Pumps: Cell Therapies Unlock a $403B Cure Economy

Dec 16, 2025, 11:53 ET Beyond Insulin Pumps: Cell Therapies Unlock a $403B Cure Economy

manufacturing convergence point are attracting institutional attention: Avant Technologies, Inc. (OTCQB: AVAI), ProKidney Corp. (NASDAQ: PROK), Mesoblast Limited (NASDAQ: MESO), Lineage Cell Therapeutics, Inc. (NYSE-A: LCTX), and BrainStorm Cell Therapeutics Inc. (OTCQB:

More news about: Equity Insider

Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.